Carmelo Muià, Emanuela Mazzon, Daniele Zito, Daniele Maiere, Domenico Britti, Concetta Crisafulli, Giacomo Oteri, Giancarlo Cordasco, Salvatore Cuzzocrea
Index: Naunyn Schmiedebergs Arch. Pharmacol. 373(1) , 51-9, (2006)
Full Text: HTML
Recent studies have demonstrated that cloricromene, a coumarin derivative, exerts protective effects in models of inflammation and shock. Tumour necrosis factor plays a pivotal role in the induction of genes involved in physiological processes, as well as in the response to inflammation. We investigated the effect of cloricromene in a rat model of periodontitis. Periodontitis was induced in rats by placing a 2/0 braided silk ligature around the lower left first molar. At day 8 the gingivomucosal tissue encircling the mandibular first molar was removed for evaluation of tumour necrosis factor production, neutrophil infiltration, tissue permeability, nitrotyrosine formation, poly (ADP-ribose) polymerase activation, radiography and histology. Ligation significantly induced an increased tumour necrosis factor production, neutrophil infiltration and a positive staining for nitrotyrosine formation and poly (ADP-ribose) polymerase activation. Ligation significantly increased Evans blue extravasation in gingivomucosal tissue and alveolar bone erosion as evaluated by radiography analysis. Intraperitonal injection of cloricromene (10 mg/kg daily for 8 days) significantly decreased all of the parameters of inflammation as described above. This suggests that cloricromene treatment, which reduced tumour necrosis factor production, may be of benefit in the treatment of periodontitis.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Cloricromenehydrochloride
CAS:74697-28-2 |
C20H27Cl2NO5 |
Cloricromene in endotoxemia: role of NF-kappaB.
2004-08-01 [Naunyn Schmiedebergs Arch. Pharmacol. 370(2) , 140-5, (2004)] |
Tumor necrosis factor induces E-selectin production in splan...
1995-04-01 [Am. J. Physiol. 268(4 Pt 2) , H1412-7, (1995)] |
Preparation and characterization of eudragit retard nanosusp...
2006-01-01 [AAPS PharmSciTech 7(1) , E27, (2006)] |
Enhancement of availability of cloricromene at brain level b...
2006-07-01 [J. Pharm. Pharmacol. 58(7) , 1001-5, (2006)] |
Effect of cloricromene on intermittent claudication. A rando...
2000-01-01 [Vasc. Med. 5(2) , 83-9, (2000)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved